The Pharmaceuticals and Medical Devices Agency (PMDA) of Japan has posted a press release titled “Press Release regarding international activities related to Pharmacopoeia.” The announcement signals PMDA’s ongoing involvement in international pharmacopoeial collaboration and standard‑setting efforts. No further details were provided in the brief notice. The full release can be accessed on the PMDA website.
Regulatory UpdatesAug 23, 2026•1 min read
PMDA Issues Press Release on International Pharmacopoeia Activities
The Japan Pharmaceuticals and Medical Devices Agency announced a new press release covering its international pharmacopoeia initiatives.
Compiled by the PharmaCountry team · Source: Pharmaceuticals and Medical Devices Agency (PMDA)
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating